High-volume breakouts
Query: Breakouts with elevated relative volume · data as of 2026-10-12
Screen for US stocks with an active breakout flag (horizontal resistance break) and relative volume > 1.2 returned 4 names as of 2026-10-12, sorted by momentum potential then relative volume: NVAX, HUM, SNAP, ATEC. Delivered one table with all requested columns (symbol, name, sector, industry, theme, 1D/1M/6M returns, relative volume, momentum potential, days since last earnings, market cap, P/E) plus per-row qualitative comments and a takeaway narrative framing the health-care-led rotation and breakout-risk considerations.
Only four US stocks broke above a horizontal resistance level on above-average volume (relative volume > 1.2x) as of October 12, 2026. Health care dominates the list — Novavax and Humana both sit in confirmed uptrends with strong multi-month momentum, while Alphatec and Snap round out the screen. The scarcity is itself the signal: with breadth flat and dispersion extreme, genuine volume-backed breakouts are rare.
Breakout Breakouts with Elevated Volume
| Symbol | Security Name | Sector | Industry | Theme | 1D Return | 1M Return | 6M Return | Relative Volume | Momentum Potential | Days Since Last Earnings | Market Cap | P/E (TTM) | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NVAX | Novavax, Inc. - Common Stock | Health Care | Biotechnology | Biopharma Drug Discovery Platforms | -0.71% | 34.39% | 56.10% | 1.4946 | 89.5 | 67 | 2.088e+09 | 4.91 | A high-beta biotech riding its strongest multi-month momentum in years, with volatility scoring near the top of the universe. The setup is speculative — small float, funding-dependent pipeline, and no near-term earnings catalyst now that the quarterly report is behind it, so the tape is driven by news flow and sector risk appetite rather than fundamentals. Breakouts in this profile can extend violently or reverse just as fast; position sizing matters more than the chart. |
| HUM | Humana Inc. | Health Care | Healthcare Plans | Property & Casualty Insurance | 0.38% | 5.78% | 119.20% | 1.3178 | 75.9 | 75 | 5.205e+10 | 40.97 | The standout of the group: a managed-care recovery story clearing a long base after a brutal stretch of medical-cost pressure. Hospital utilization and Medicare Advantage margin trends are the swing factor, and any stabilization in cost trend is being rewarded aggressively by a market still underweight the group. Health care is one of only two sectors with positive one-month returns, giving this breakout a supportive sector tailwind. Watch the next guidance update as the real catalyst — the stock has already re-rated ahead of it. |
| SNAP | Snap Inc. | Communication Services | Internet Content & Information | Ad-Tech & Digital Advertising, Social Media Platforms | 4.82% | 14.96% | 26.80% | 1.2639 | 59.6 | 69 | 1.104e+10 | — | A beaten-down social media name attempting a turn off depressed levels. The bull case rests on ad-market improvement and monetization of newer formats, but the competitive backdrop is unforgiving and the shares carry a large supply of overhead resistance from prior declines. Social media is a laggard theme over the past year, so this is a counter-trend breakout — one that needs sustained volume confirmation rather than a single session pop to be credible. |
| ATEC | Alphatec Holdings, Inc. | Health Care | Medical Devices | Medical Devices & Surgical Technologies | 5.44% | 6.33% | 0.00% | 1.352 | 37.3 | 68 | 1.738e+09 | — | A small-cap spine-surgery player breaking out in tandem with a broad medtech bid that has been one of the market's quiet leaders. Growth comes from procedural adoption of its surgical platform, but the balance sheet and reliance on external financing keep risk elevated. Medtech strength is a genuine theme tailwind, making this a higher-quality small-cap setup than the raw volatility suggests — provided the sector rotation holds. |
Takeaway
What this screen shows
A horizontal-resistance breakout confirmed by above-average volume is one of the more reliable momentum triggers — but it is rare right now. Only four US stocks cleared the filter of an active resistance break paired with relative volume above 1.2x on the latest session, a reflection of a tape where breadth is flat and dispersion is extreme rather than uniformly risk-on.
Reading the list
- Health care owns three of the four names. That is not a coincidence: health care and staples are the only US sectors with positive one-month returns, and money is rotating into medtech, managed care and select biotech from both rate-sensitive cyclicals and the AI-hardware trade. A breakout inside a supportive sector has a higher follow-through probability than one fighting its group.
- Quality of setup varies sharply. Humana is the cleanest — a large-cap recovery clearing a long base with improving cost-trend optics. Alphatec benefits from the same medtech bid but carries small-cap financing risk. Novavax pairs extreme volatility with extreme momentum, and Snap is a counter-trend reversal attempt in a lagging theme.
- The volume confirmation is meaningful but not confirmation of trend. Returns in our data are percentage points and the relative-volume reading only tells you today's participation was above normal — it does not guarantee institutional accumulation. Names that break out on a single volume spike and then fade back inside the range are the classic trap.
Risk framing
The broader market message is cautionary for chasing: among stocks with very high relative volume, a large share have been under distribution over the past month, and the average decliner today lost far more than the average gainer. Treat these as setups to monitor for follow-through rather than completed trend changes, and use the nearest support level as the invalidation point.
Run a version of this yourself
Describe the idea in plain English and Relaxfolio returns a researchable shortlist with the charts, fundamentals, and risks attached.
Educational research tool — not investment advice. A screen is a starting point, not a recommendation.